| Literature DB >> 35664547 |
Xiao-Li Wang1, Fang-Rong Cai1, Yun-Xia Gao2, Jian Zhang1, Ming Zhang3.
Abstract
BACKGROUND: Diabetic retinopathy (DR) is a diabetic complication that can severely affect the patients' vision, eventually leading to blindness. DR is the most important manifestation of diabetic micro-vasculopathy and is mainly related to the course of diabetes and the degree of blood glucose control, while the age of diabetes onset, sex, and type of diabetes have little influence on it. AIM: To explore the changes in blood oxygen saturation and oxidative stress indices of retinal vessels in patients with DR.Entities:
Keywords: Blood oxygen saturation; Diabetes; Diabetic retinopathy; Oxidative stress; Retinopathy
Year: 2022 PMID: 35664547 PMCID: PMC9134027 DOI: 10.4239/wjd.v13.i5.408
Source DB: PubMed Journal: World J Diabetes ISSN: 1948-9358
The baseline data of the study subjects, n (%)
|
|
|
|
|
|
| Age (yr) | 65.8 ± 7.0 | 64.4 ± 8.1 | 1.284 | 0.201 |
| BMI (kg/m2) | 24.6 ± 1.9 | 24.4 ± 2.0 | 0.713 | 0.477 |
| Sex | 1.195 | 0.274 | ||
| Male | 51 (54.26) | 62 (62.00) | ||
| Female | 43 (45.74) | 38 (38.00) | ||
| Affected side distribution | 1.959 | 0.162 | ||
| Left side | 47 (50.00) | 60 (60.00) | ||
| Right | 47 (50.00) | 40 (40.00) | ||
| Hypertension | 2.561 | 0.110 | ||
| Yes | 18 (19.15) | 29 (29.00) | ||
| No | 76 (80.85) | 71 (71.00) | ||
| Dyslipidemia | 1.909 | 0.176 | ||
| Yes | 32 (34.04) | 25 (25.00) | ||
| No | 62 (65.96) | 75 (75.00) |
DR: Diabetic retinopathy; BMI: Body mass index.
Figure 1Histograms of retinal artery, venous oxygen saturation, diameters of retinal arteries and veins of two groups of subjects. A: Histograms of retinal artery and venous oxygen saturation; B: Histograms of the diameters of retinal arteries and veins. DR: Diabetic retinopathy.
Comparison of serum oxidative stress indicators between the two groups of subjects (mean ± SD)
|
|
|
|
|
|
| MDA (μmol/L) | 7.50 ± 1.50 | 3.82 ± 0.84 | 21.246 | < 0.05 |
| 8-HdG (ng/mL) | 107.50 ± 22.51 | 49.63 ± 8.11 | 24.102 | < 0.05 |
| SOD (U/L) | 71.33 ± 14.80 | 93.64 ± 17.26 | -9.637 | < 0.05 |
| GSH (mg/L) | 163.81 ± 38.51 | 211.07 ± 25.46 | -10.14 | < 0.05 |
MDA: Serum malondialdehyde; 8-HdG: 8-hydroxydehydroguanosine; SOD: superoxide dismutase; GSH: Reduced glutathione.
Figure 2Histogram of retinal artery, venous oxygen saturation and vein diameters in patients with different diabetic retinopathy stages. A: Histogram of retinal artery and venous oxygen saturation; B: Histogram of retinal artery and vein diameters. PDR: Proliferative diabetic retinopathy; NPDR: Non-proliferative diabetic retinopathy.
Comparison of serum oxidative stress indexes in patients with different diabetic retinopathy stages (mean ± SD)
|
|
|
|
|
|
| MDA (μmol/L) | 6.11 ± 1.38 | 9.55 ± 1.43 | -11.688 | < 0.05 |
| 8-HdG (ng/mL) | 90.53 ± 20.54 | 132.51 ± 19.82 | -9.862 | < 0.05 |
| SOD (U/L) | 83.02 ± 11.68 | 54.10 ± 13.01 | 11.249 | < 0.05 |
| GSH (mg/L) | 187.46 ± 32.74 | 128.96 ± 26.74 | 9.135 | < 0.05 |
MDA: Serum malondialdehyde; 8-HdG: 8-hydroxydehydroguanosine; SOD: superoxide dismutase; GSH: Reduced glutathione.
Figure 3Results of retinal color images of different subjects. A: The control group; B: The simple diabetic retinopathy (DR) group; C: The proliferative DR group.